103 related articles for article (PubMed ID: 2957131)
1. Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.
O'Gorman MR; Oger J; Kastrukoff LF
Clin Exp Immunol; 1987 Jan; 67(1):66-75. PubMed ID: 2957131
[TBL] [Abstract][Full Text] [Related]
2. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.
Oger JJ; Antel JP; Kuo HH; Arnason BG
Ann Neurol; 1982 Feb; 11(2):177-81. PubMed ID: 6462102
[TBL] [Abstract][Full Text] [Related]
3. Abnormal regulation of in vitro IgG production in multiple sclerosis.
Kelly RE; Ellison GW; Myers LW; Goymerac V; Larrick SB; Kelley CC
Ann Neurol; 1981 Mar; 9(3):267-72. PubMed ID: 6452852
[TBL] [Abstract][Full Text] [Related]
4. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
[TBL] [Abstract][Full Text] [Related]
5. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
Auer IO; Röder A; Fröhlich J
Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
[TBL] [Abstract][Full Text] [Related]
6. T cell regulation of polyclonally induced immunoglobulin secretion in humans.
Rosenkoetter M; Reder AT; Oger JJ; Antel JP
J Immunol; 1984 Apr; 132(4):1779-83. PubMed ID: 6230393
[TBL] [Abstract][Full Text] [Related]
7. Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon.
Panitch HS; Francis GS; Hooper CJ; Merigan TC; Johnson KP
Ann Neurol; 1985 Oct; 18(4):434-8. PubMed ID: 2416265
[TBL] [Abstract][Full Text] [Related]
8. Interferon beta augments suppressor cell function in multiple sclerosis.
Noronha A; Toscas A; Jensen MA
Ann Neurol; 1990 Feb; 27(2):207-10. PubMed ID: 2138445
[TBL] [Abstract][Full Text] [Related]
9. In vitro stimulated peripheral blood lymphocytes from multiple sclerosis patients produce idiotypes of oligoclonal CSF IgG.
Nagelkerken LM; Out TA
J Immunol; 1983 Nov; 131(5):2328-31. PubMed ID: 6685156
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
11. Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: comparison with a classification system on CD4-naïve cells.
Livaditi O; Giamarellos-Bourboulis EJ; Kakkas I; Kapsimali V; Lymberi P; Papastariades C; Douzinas EE
Immunol Lett; 2007 Dec; 114(2):103-9. PubMed ID: 17977604
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.
Yan S; Marguet D; Dobers J; Reutter W; Fan H
Eur J Immunol; 2003 Jun; 33(6):1519-27. PubMed ID: 12778469
[TBL] [Abstract][Full Text] [Related]
13. Suppression of pokeweed mitogen-stimulated immunoglobulin production in patients with rheumatoid arthritis after treatment with total lymphoid irradiation.
Kotzin BL; Strober S; Kansas GS; Terrell CP; Engleman EG
J Immunol; 1984 Feb; 132(2):1049-55. PubMed ID: 6228589
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
16. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
Haahr S; Møller-Larsen A; Pedersen E
Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
[TBL] [Abstract][Full Text] [Related]
17. Defective immunoregulation in multiple sclerosis.
Goust JM; Hoffman PM; Pryjma J; Hogan EL; Fudenberg HH
Ann Neurol; 1980 Nov; 8(5):526-33. PubMed ID: 7436394
[TBL] [Abstract][Full Text] [Related]
18. Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.
Bania MB; Antel JP; Reder AT; Nicholas MK; Arnason BG
J Clin Invest; 1986 Aug; 78(2):582-6. PubMed ID: 2942563
[TBL] [Abstract][Full Text] [Related]
19. [Changes in lymphocyte subsets s and treatment with beta interferon in active multiple sclerosis].
Gata JM; García-Moreno JM; Dinca L; Sánchez-Margalet V; Navarro G; Izquierdo G
Rev Neurol; 1998 Dec; 27(160):939-42. PubMed ID: 9951008
[TBL] [Abstract][Full Text] [Related]
20. [The study on in vitro antibody secretion of B lymphocyte in patient with pregnancy induced hypertension].
Zheng Y; Chen Z; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 1998 Dec; 33(12):717-9. PubMed ID: 10806657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
